Sinfatin SL is a biotechnology company established in 2021 in Spain. We focus in the repositioning of medicines for the treatment of nervous system disorders. We leverage known mechanism of action, safety and efficacy profiles of existing medicinal products, and identify new therapeutic applications. This strategy allows us to accelerate the development of safe and effective therapies for unmet medical needs, especially in nervous system diseases.
Our highly qualified team has extensive expertise in clinical research and drug development that spans drug development strategy, trial design and execution, data analysis and communication, and regulatory strategy, enabling cost-effective and time-efficient development while ensuring full regulatory compliance. We are committed to scientific rigor, ethical standards, and improving patient quality of life.
Our core mission is to improve patient care and quality of life by repurposing safe, effective therapies for neurological conditions, addressing unmet clinical needs. We are committed to scientific excellence, ethical research, and innovative approaches that bring meaningful treatments to those affected by CNS conditions. 
Our vision is to become a global leading force in transforming the treatment landscape for central nervous system diseases, especially targeting mental and physical fatigue and walking disabilities.

SINFATIN, S.L.

Org chart

Teams

Offices

SINFATIN, S.L.

Org chart

Teams

Offices

Related companies